期刊文献+

HPLC测定人血浆中的塞克硝唑及其药物动力学参数 被引量:1

Determination of Secnidazole in human plasma and study on pharmacokinetics by HPLC
下载PDF
导出
摘要 目的建立测定人血浆中塞克硝唑浓度的方法。方法血浆样品经10%三氯醋酸沉淀蛋白后,用HPLC法,以乙腈-0.05 mol.L-1枸橼酸缓冲液(pH4.0,18:82)为流动相,经Diamonsil-C18色谱柱分离,310 nm检测。结果塞克硝唑在1.0~60.0μg.ml-1与待测物和内标物峰面积比的线性关系良好,最低检测浓度为1.0μg.ml-1;低、中、高3个浓度的提取回收率为82.10%~84.69%,日内、日间RSD低于6.09%。结论所建方法准确、操作简单,可满足临床药物动力学研究的要求。 OBJECTIVE To establish a method for determination of Secnidazole in human serum. METHODS Serum protein was precipitated with trichloroacetic acid. The analysis was conducted with a Diamonsil - C18 ( 150 mm × 4. 6 mm,5 μm) column, and acetonitrile-0. 05 mol·L^-1 citric buffer( pH4. 0,18 : 82 ) was served as mobile phase with the detecting wavelengh at 310 nm . RESULTS The linear range of Secnidazole was 1.0 - 60. 0 μg·ml^-1 ( r = 0. 9990) and the average recoveries were 82. 10% - 84. 69 % at three different concentrations . The RSD of intra - and inter - day were 1.86% - 6. 09% . CONCLUSION This method is suitable for the pharmacokinetic study of Secnidazole .
出处 《华西药学杂志》 CAS CSCD 北大核心 2007年第4期406-407,共2页 West China Journal of Pharmaceutical Sciences
关键词 塞克硝唑 高效液相色谱法 血药浓度 Secnidazole HPLC Plasma drug concentration
  • 相关文献

参考文献4

  • 1张立红,吴松.塞克硝唑的药理及临床应用[J].中国新药杂志,2002,11(10):765-766. 被引量:28
  • 2张铃敏,蒋学华,杨俊毅,周静.国产塞克硝唑片剂与胶囊剂的生物利用度研究[J].中国抗生素杂志,2005,30(2):114-116. 被引量:1
  • 3Ravi SK,Naidu MU,Sekhar EC,et al.Rapid and selective analysis of secnidazole in human plasma using high-performance liquid chromatography with ultraviolet detection[J].J Chromatogr B Biomed Sci Appl,1997,691:208-211.
  • 4Gillis JC,Wiseman LR.Secnidazole,A review of its antimicrobial activity,pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis[J].Drugs,1996,51:621-638.

二级参考文献10

  • 1唐汉祥.替硝唑的临床药理研究[J].中国新药杂志,1997,6(3):180-182. 被引量:13
  • 2.中华人民共和国药典[S]2000年版第二部[M].中华人民共和国药典委员会,.附录193.
  • 3倪宗瓒.医学统计学[M](第二版)[M].北京:人民卫生出版社,2000..
  • 4J Dupouy-Camet. Single dose treatments in tropical infectious diarrhoea: the place of secnidazole[J]. Drug Invest, 1994, 8 (Suppl 1):S35 - S46.
  • 5Lamp KC, Freeman CD, Klutman NE, et al. Pharmacokinetics and ph. armacodynamics of the nitroimidazole antimicrobials [J].Clin Pharrmacokinet, 1999, 36(5): 353 - 373.
  • 6Gillis JC, Wiseman LR. Secnidazole[J]. Drugs, 1996, 51(4) :621 -638.
  • 7Botero D. An overview of the clinical experience of secnidazole in giardiasis and amoebiasis[J]. Drug Invest, 1994, 8 (Suppl 1) :S47 -S52.
  • 8Bagnoli VR. An overview of the clinical experience with secnidazole in bacterial vaginosis and trichomoniasis [ J ]. Drug Invest,1994, 8(Suppl 1 ): S53 - S60.
  • 9戚燕,单慧军,吴松.反相高效液相色谱法测定塞克硝唑的含量及其有关物质[J].中国新药杂志,2002,11(4):294-296. 被引量:11
  • 10周燕文.塞克硝唑的药理和临床应用[J].广西医学,2002,24(10):1585-1589. 被引量:7

共引文献27

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部